Skip to main content
logo
Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
24.69
-0.13 (-0.52%)
At close: Apr 2, 2026, 4:00 PM EDT
24.70
+0.01 (0.04%)
After-hours: Apr 2, 2026, 7:54 PM EDT

Catalyst Pharmaceuticals Market Cap

Catalyst Pharmaceuticals has a market cap or net worth of $3.02 billion as of April 2, 2026. Its market cap has increased by 9.85% in one year.

Market Cap
3.02B
Enterprise Value
2.31B
1-Year Change
9.85%
Ranking
#1718
Category
Mid-Cap
Stock Price
$24.69

Market Cap Chart

Since November 8, 2006, Catalyst Pharmaceuticals's market cap has increased from $76.40M to $3.02B, an increase of 3,846.65%. That is a compound annual growth rate of 20.85%.

History

DateMarket Cap% Change
Apr 2, 20263.02B5.10%
Dec 31, 20252.87B15.25%
Dec 31, 20242.49B38.90%
Dec 29, 20231.79B-7.42%
Dec 30, 20221.94B177.28%
Dec 31, 2021698.10M101.65%
Dec 31, 2020346.20M-10.40%
Dec 31, 2019386.40M95.84%
Dec 31, 2018197.30M-40.80%
Dec 29, 2017333.30M283.10%
Dec 30, 201687.00M-57.12%
Dec 31, 2015202.90M-1.17%
Dec 31, 2014205.30M94.41%
Dec 31, 2013105.60M599.34%
Dec 31, 201215.10M-52.66%
Dec 30, 201131.90M66.15%
Dec 31, 201019.20M68.42%
Dec 31, 200911.40M-54.94%
Dec 31, 200825.30M-41.44%
Dec 31, 200743.20M-28.60%
Dec 29, 200660.50M-20.81%
Nov 8, 200676.40M-
View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Denali Therapeutics3.27B
Dyne Therapeutics3.11B
Tango Therapeutics3.09B
Telix Pharmaceuticals3.03B
Tarsus Pharmaceuticals2.98B
Alumis2.97B
Arcutis Biotherapeutics2.93B
Vera Therapeutics2.92B
Market Cap Rankings